Injectable Targeted Therapy Global Market Report 2025
상품코드:1855906
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
주사 표적치료 시장 규모는 최근 급속히 확대하고 있습니다. 2024년 579억 7,000만 달러에서 2025년에는 642억 2,000만 달러로, CAGR 10.8%로 확대합니다. 지난 기간 중 성장의 원동력은 주사 표적 치료 임상시험 증가, 정밀 종양학 및 면역 요법에 대한 관심 증가, 생물제제에 대한 보조금 상환 정책 확대, 저침습적 치료 옵션에 대한 환자 선호도 증가, 새로운 주사 표적 치료제에 대한 규제 당국의 승인 증가 등입니다.
주사 표적치료제 시장 규모는 향후 수년간 급성장할 것으로 예측됩니다. 2029년에는 CAGR 10.4%로 954억 6,000만 달러로 성장할 것입니다. 예측 기간 중의 성장에는 만성질환 및 희귀질환의 유병률 증가, 맞춤형 의료에 대한 수요 증가, 기존 치료법보다 생물제제의 채택 확대, 의료 전문가들의 표적치료에 대한 인식 증가, 생명공학 및 의약품 연구개발에 대한 투자 증가 등이 영향을 미칠 것으로 보입니다. 등이 배경이 되고 있습니다. 예측 기간의 주요 동향으로는 단클론 항체 기술 혁신, 환자 모니터링을 위한 디지털 헬스 플랫폼의 통합, 항체약물접합체 개발, 암 치료를 위한 이중특이성항체의 발전, 맞춤형 의료 접근법의 발전 등을 들 수 있습니다.
주사 표적 치료는 질병의 원인이 되는 특정 단백질이나 세포를 정확하게 타겟으로 하여 주사를 통해 약물을 투여하는 치료법입니다. 이 접근법은 기존 치료법에 비해 건강한 조직의 손상을 최소화하면서 암과 같은 질병을 보다 효과적으로 치료하는 것을 목표로 합니다.
주사 표적치료제의 주요 유형은 모노클로널 항체, 저분자, 면역독, 기타 등이 있습니다. 모노클로널 항체는 병변 세포의 표적 단백질에 특이적으로 결합하도록 설계된 실험실에서 제작된 항체입니다. 주요 작용기전으로는 신호전달 경로의 표적 억제, 세포독성 약물의 표적 전달, 면역 조절 등이 있습니다. 이러한 치료제는 일반적으로 정맥, 피하, 근육내 등의 경로로 투여됩니다. 종양학, 심장대사학, 면역학, 감염학, 신경과학, 안과학 등 다양한 분야에 적용되어 병원, 전문 클리닉, 연구소 등 최종사용자에게 서비스를 제공합니다.
2025년 봄, 미국의 갑작스러운 관세 인상과 이에 따른 무역 마찰은 제약회사에 심각한 영향을 미치고 있습니다. 이익이 적은 제네릭 의약품 제조업체는 특히 취약하며, 일부 기업은 수익성이 낮은 의약품의 생산을 축소하기도 합니다. 생명공학 기업은 관세와 관련된 특수 시약의 부족으로 인해 임상시험이 지연되고 있습니다. 이에 업계는 인도와 유럽에서 원료의약품 생산을 확대하고, 재고 비축을 늘리며, 필수의약품의 무역 면제를 요구하고 있습니다.
이 조사 보고서는 주사 표적 치료 산업 세계 시장 규모, 지역별 점유율, 주사 표적 치료 시장 점유율을 가진 경쟁사, 상세한 주사 표적 치료 시장 부문, 시장 동향 및 비즈니스 기회, 주사 표적 치료 산업에서 성공하기 위해 필요한 데이터 등 주사 표적 치료 시장 통계를 제공합니다. Business Research Company의 새로운 보고서 시리즈 중 하나입니다. 이 주사 표적 치료 시장 조사 보고서는 업계의 현재와 미래 시나리오를 자세히 분석하여 필요한 모든 것을 완벽한 관점으로 제공합니다.
맞춤형 의료에 대한 수요 증가는 주사 표적치료제 시장의 확대를 촉진할 것으로 예측됩니다. 맞춤형 의료는 개인의 유전적, 환경적, 생활습관적 요인에 따라 예방, 진단, 치료를 조정하는 접근법입니다. 이러한 맞춤형 의료로의 전환은 유전적 변이를 더 깊이 이해하고, 시행착오를 줄이는 동시에 환자 결과를 개선하고, 보다 정확한 치료를 가능하게 하는 유전체학의 발전에 힘입은 바 큽니다. 주사 표적 치료는 환자 고유의 분자 및 유전자 질환 프로파일을 구체적으로 타겟팅한 치료를 제공하여 효능을 높이고 부작용을 최소화함으로써 맞춤형 의료를 지원합니다. 예를 들어 2024년 2월 미국 비영리단체인 맞춤형 의료연합(Personalized Medicine Coalition)은 2023년 FDA가 희귀질환 환자를 위해 16개의 새로운 개인맞춤형 치료제를 승인했으며, 이는 2022년 6개에서 증가한 수치라고 보고했습니다. 이번 신규 승인에는 7개의 암 치료제와 3개의 기타 질환 치료제가 포함되었습니다. 그 결과, 개인 맞춤형 치료에 대한 수요 증가가 주사 표적치료제 시장의 성장을 촉진하고 있습니다.
주사제 표적치료제 시장의 주요 기업은 약물전달을 개선하고, 환자의 순응도를 높이며, 특정 질병 경로를 보다 효과적으로 표적화할 수 있는 피하주사 등 혁신적인 솔루션을 개발하는 데 주력하고 있습니다. 피하주사는 피부 바로 아래 지방조직에 약물을 전달하여 서서히 혈류에 흡수되는 방식입니다. 예를 들어 2025년 8월 일본 제약회사 에자이(Eisai)는 미국 생명공학 기업 바이오젠(Biogen)과 제휴하여 조기 알츠하이머병 치료제 LEQEMBI IQLIK의 FDA 승인을 획득했습니다. 이 주 1회 피하주사는 초기 정맥주사 치료 후 유지요법을 목적으로 하며, 환자는 집에서 자가주사를 할 수 있습니다. 이 치료제는 알츠하이머병의 진행에 관여하는 아밀로이드 베타 플라크 및 원섬유를 표적으로 하여 이를 제거함으로써 효과를 발휘합니다. 이 제제는 정맥주사 대비 치료시간과 전신 부작용을 줄여 환자의 독립성을 높이고, 수액 센터를 자주 방문해야 하는 불편함을 줄여줍니다.
2025년 9월, 스위스에 본사를 둔 제약회사 노바티스(Novartis AG)는 토르말린 바이오(Tourmaline Bio)를 비공개 금액으로 인수했습니다. 이번 인수를 통해 노바티스는 동맥경화성 심혈관질환의 잔존 염증 위험에 대응하는 IL-6 표적 항염증약 파시베키트를 통해 심혈관계 포트폴리오를 강화 및 다양화할 수 있게 되었습니다. 이번 추가를 통해 노바티스는 염증성 심혈관 질환 치료의 최전선에 위치하게 되었으며, 이 시장에서 큰 성장 기회를 확보할 수 있게 되었습니다. 미국에 본사를 둔 생명공학 기업인 Tourmaline Bio Inc.는 주사를 통한 표적 치료를 전문으로 하는 기업입니다.
주사 표적치료제 시장은 이중특이성항체, 항체약물접합체, 면역관문억제제의 매출로 구성되어 있습니다. 이 시장의 가치는 '팩토리 게이트' 가치, 즉 상품의 제조업체 또는 제작자가 다른 사업체(다운스트림 제조업체, 도매업체, 유통업체, 소매업체 포함) 또는 최종 고객에게 직접 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품을 만든 사람이 판매하는 관련 서비스도 포함됩니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 주사 표적치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 주사 표적치료 시장 : 성장률 분석
세계의 주사 표적치료 시장 실적 : 규모와 성장, 2019-2024
세계의 주사 표적치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 주사 표적치료 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 주사 표적치료 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
모노클로널 항체
저분자
면역독소
기타 유형
세계의 주사 표적치료 시장 : 작용기서별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
신호전달 경로 표적 저해
세포 독성약제 표적 전달
면역 조절
세계의 주사 표적치료 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
정맥주사
피하 주사
근육내
세계의 주사 표적치료 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
종양학
심장 대사
면역학
감염증
신경과학
안과
기타 용도
세계의 주사 표적치료 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
전문 클리닉
조사 연구소
세계의 주사 표적치료 시장 : 서브 세분화 모노클로널 항체, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
완전 인간 항체
인간화 항체
키메라 항체
세계의 주사 표적치료 시장 : 서브 세분화 저분자, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
티로신 키나아제 저해제
프로테아좀 저해제
Mtor 저해제
세계의 주사 표적치료 시장 : 서브 세분화 면역독소, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
재조합 면역독소
케미컬 컨쥬게이트
융합단백질
세계의 주사 표적치료 시장 : 서브 세분화 기타 유형, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
항체약물접합체
이중특이성항체
펩티드 기반 치료제
제7장 지역별·국가별 분석
세계의 주사 표적치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 주사 표적치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
주사 표적치료 시장 : 경쟁 구도
주사 표적치료 시장 : 기업 개요
Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Bayer AG
Sanofi SA
Novartis AG
AstraZeneca plc
Bristol-Myers Squibb Company
GlaxoSmithKline plc
Eli Lilly and Company
Amgen Inc.
Gilead Sciences Inc.
Regeneron Pharmaceuticals Inc.
Biogen Inc.
Eisai Co. Ltd.
Genentech Inc.
Beigene Ltd.
Agenus Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
주사 표적치료 시장 2029 : 새로운 기회를 제공하는 국가
주사 표적치료 시장 2029 : 새로운 기회를 제공하는 부문
주사 표적치료 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Injectable targeted therapy involves medications administered through injection that precisely target specific proteins or cells responsible for a disease. This approach aims to treat conditions such as cancer more effectively while minimizing damage to healthy tissues compared to conventional treatments.
The primary types of injectable targeted therapy are monoclonal antibodies, small molecules, immunotoxins, and others. Monoclonal antibodies are laboratory-engineered antibodies designed to bind specifically to target proteins on diseased cells. The primary mechanisms of action include targeted inhibition of signal transduction pathways, targeted delivery of cytotoxic agents, and immunomodulation. These therapies are commonly administered via intravenous, subcutaneous, or intramuscular routes. They are applied across diverse fields such as oncology, cardiometabolism, immunology, infectious diseases, neuroscience, ophthalmology, and others, serving end users including hospitals, specialty clinics, and research laboratories.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The injectable targeted therapy market research report is one of a series of new reports from The Business Research Company that provides injectable targeted therapy market statistics, including injectable targeted therapy industry global market size, regional shares, competitors with an injectable targeted therapy market share, detailed injectable targeted therapy market segments, market trends and opportunities, and any further data you may need to thrive in the injectable targeted therapy industry. This injectable targeted therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The injectable targeted therapy market size has grown rapidly in recent years. It will grow from $57.97 billion in 2024 to $64.22 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth during the historic period was driven by the increasing number of clinical trials for injectable targeted therapies, rising focus on precision oncology and immunotherapy, expanding supportive reimbursement policies for biologic therapies, growing patient preference for minimally invasive treatment options, and increasing regulatory approvals for new injectable targeted therapies.
The injectable targeted therapy market size is expected to see rapid growth in the next few years. It will grow to $95.46 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth during the forecast period is fueled by rising prevalence of chronic and rare diseases, growing demand for personalized medicine, wider adoption of biologics over conventional therapies, increasing awareness of targeted therapies among healthcare professionals, and higher investments in biotechnology and pharmaceutical research and development. The primary trends in the forecast period include technology driven innovations in monoclonal antibodies, integration of digital health platforms for patient monitoring, developments in antibody-drug conjugates, advancements in bispecific antibodies for cancer treatment, and progress in personalized medicine approaches.
The growing demand for personalized medicine is expected to drive the expansion of the injectable targeted therapy market. Personalized medicine is an approach that tailors prevention, diagnosis, and treatment based on an individual's genetic, environmental, and lifestyle factors. This shift toward personalized medicine is largely fueled by advances in genomics, which allow for a deeper understanding of genetic variations and enable more precise treatments that enhance patient outcomes while reducing the trial-and-error approach in therapies. Injectable targeted therapy supports personalized medicine by delivering treatments that specifically target a patient's unique molecular or genetic disease profile, improving efficacy and minimizing side effects. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit, reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. These new approvals included seven cancer drugs and three for other diseases. As a result, the increasing demand for personalized treatments is driving growth in the injectable targeted therapy market.
Leading companies in the injectable targeted therapy market are focusing on creating innovative solutions such as subcutaneous injections to improve drug delivery, enhance patient compliance, and target specific disease pathways more effectively. Subcutaneous injections involve delivering medication just beneath the skin into the fatty tissue, where it is gradually absorbed into the bloodstream. For instance, in August 2025, Eisai Co., Ltd., a Japan-based pharmaceutical company, partnered with Biogen Inc., a US-based biotechnology company, and received FDA approval for LEQEMBI IQLIK, a treatment for early Alzheimer's disease. This once-weekly subcutaneous injection is designed for maintenance treatment after an initial intravenous therapy, allowing patients to self-administer at home. The treatment works by targeting and clearing amyloid beta plaques and protofibrils, which contribute to Alzheimer's progression. By reducing treatment time and systemic side effects compared to intravenous infusions, the formulation offers patients greater independence and reduces the need for frequent visits to infusion centers.
In September 2025, Novartis AG, a pharmaceutical company based in Switzerland, acquired Tourmaline Bio Inc. for an undisclosed amount. This acquisition allows Novartis to enhance and diversify its cardiovascular portfolio with pacibekitug, a novel anti-inflammatory therapy that targets IL-6 to address residual inflammatory risk in atherosclerotic cardiovascular disease. With this addition, Novartis positions itself at the forefront of inflammation-driven cardiovascular treatments and aims to capture significant growth opportunities in this market. Tourmaline Bio Inc., a US-based biotechnology company, specializes in injectable targeted therapies.
Major players in the injectable targeted therapy market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Novartis AG, AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Eisai Co. Ltd., Genentech Inc., Beigene Ltd., Agenus Inc., and Xilio Therapeutics Inc.
North America was the largest region in the injectable targeted therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in injectable targeted therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the injectable targeted therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The injectable targeted therapy market consists of sales of bispecific antibodies, antibody-drug conjugates, and immune checkpoint inhibitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Injectable Targeted Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on injectable targeted therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for injectable targeted therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The injectable targeted therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Monoclonal Antibodies; Small-Molecules; Immunotoxins; Other Types
2) By Mechanism Of Action: Targeted Inhibition of Signal Transduction Pathways; Targeted Delivery Of Cytotoxic Agents; Immunomodulation
3) By Route Of Administration: Intravenous; Subcutaneous; Intramuscular
4) By Application: Oncology; Cardiometabolism; Immunology; Infectious Diseases; Neuroscience; Ophthalmology; Other Applications
5) By End User: Hospitals; Specialty Clinics; Research Laboratories
Subsegments:
1) By Monoclonal Antibodies: Fully Human Antibodies; Humanized Antibodies; Chimeric Antibodies
2) By Small-Molecules: Tyrosine Kinase Inhibitors; Proteasome Inhibitors; Mtor Inhibitors
3) By Immunotoxins: Recombinant Immunotoxins; Chemical Conjugates; Fusion Proteins
4) By Other Types: Antibody-Drug Conjugates; Bispecific Antibodies; Peptide-Based Therapeutics
Companies Mentioned: Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Pfizer Inc.; AbbVie Inc.; Bayer AG; Sanofi SA; Novartis AG; AstraZeneca plc; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Eli Lilly and Company; Amgen Inc.; Gilead Sciences Inc.; Regeneron Pharmaceuticals Inc.; Biogen Inc.; Eisai Co. Ltd.; Genentech Inc.; Beigene Ltd.; Agenus Inc.; Xilio Therapeutics Inc.
3. Injectable Targeted Therapy Market Trends And Strategies
4. Injectable Targeted Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Injectable Targeted Therapy Growth Analysis And Strategic Analysis Framework
5.1. Global Injectable Targeted Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Injectable Targeted Therapy Market Growth Rate Analysis
5.4. Global Injectable Targeted Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Injectable Targeted Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Injectable Targeted Therapy Total Addressable Market (TAM)
6.1. Global Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Small-Molecules
Immunotoxins
Other Types
6.2. Global Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeted Inhibition Of Signal Transduction Pathways
Targeted Delivery Of Cytotoxic Agents
Immunomodulation
6.3. Global Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous
Subcutaneous
Intramuscular
6.4. Global Injectable Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Cardiometabolism
Immunology
Infectious Diseases
Neuroscience
Ophthalmology
Other Applications
6.5. Global Injectable Targeted Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Research Laboratories
6.6. Global Injectable Targeted Therapy Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fully Human Antibodies
Humanized Antibodies
Chimeric Antibodies
6.7. Global Injectable Targeted Therapy Market, Sub-Segmentation Of Small-Molecules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tyrosine Kinase Inhibitors
Proteasome Inhibitors
Mtor Inhibitors
6.8. Global Injectable Targeted Therapy Market, Sub-Segmentation Of Immunotoxins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Immunotoxins
Chemical Conjugates
Fusion Proteins
6.9. Global Injectable Targeted Therapy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibody-Drug Conjugates
Bispecific Antibodies
Peptide-Based Therapeutics
7. Injectable Targeted Therapy Market Regional And Country Analysis
7.1. Global Injectable Targeted Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Injectable Targeted Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Injectable Targeted Therapy Market
9.1. China Injectable Targeted Therapy Market Overview
9.2. China Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Injectable Targeted Therapy Market
10.1. India Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Injectable Targeted Therapy Market
11.1. Japan Injectable Targeted Therapy Market Overview
11.2. Japan Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Injectable Targeted Therapy Market
12.1. Australia Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Injectable Targeted Therapy Market
13.1. Indonesia Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Injectable Targeted Therapy Market
14.1. South Korea Injectable Targeted Therapy Market Overview
14.2. South Korea Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Injectable Targeted Therapy Market
15.1. Western Europe Injectable Targeted Therapy Market Overview
15.2. Western Europe Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Injectable Targeted Therapy Market
16.1. UK Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Injectable Targeted Therapy Market
17.1. Germany Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Injectable Targeted Therapy Market
18.1. France Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Injectable Targeted Therapy Market
19.1. Italy Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Injectable Targeted Therapy Market
20.1. Spain Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Injectable Targeted Therapy Market
21.1. Eastern Europe Injectable Targeted Therapy Market Overview
21.2. Eastern Europe Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Injectable Targeted Therapy Market
22.1. Russia Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Injectable Targeted Therapy Market
23.1. North America Injectable Targeted Therapy Market Overview
23.2. North America Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Injectable Targeted Therapy Market
24.1. USA Injectable Targeted Therapy Market Overview
24.2. USA Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Injectable Targeted Therapy Market
26.1. South America Injectable Targeted Therapy Market Overview
26.2. South America Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Injectable Targeted Therapy Market
27.1. Brazil Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Injectable Targeted Therapy Market
28.1. Middle East Injectable Targeted Therapy Market Overview
28.2. Middle East Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Injectable Targeted Therapy Market
29.1. Africa Injectable Targeted Therapy Market Overview
29.2. Africa Injectable Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Injectable Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Injectable Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Injectable Targeted Therapy Market Competitive Landscape And Company Profiles
